a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders
Industry PharmaceuticalsMajor
A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with GILD. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then GILD could also see price increases.
Ticker / NAME | Correlation To BIIB | 1D Price Change % | ||
---|---|---|---|---|
BIIB | 100% | +0.04% | ||
GILD - BIIB | 35% Loosely correlated | +0.89% | ||
OGN - BIIB | 33% Poorly correlated | -1.21% | ||
NVS - BIIB | 31% Poorly correlated | -1.98% | ||
PFE - BIIB | 31% Poorly correlated | -2.45% | ||
AZN - BIIB | 28% Poorly correlated | -2.17% | ||
More |
Ticker / NAME | Correlation To BIIB | 1D Price Change % |
---|---|---|
BIIB | 100% | +0.04% |
autoimmune theme (3 stocks) | 98% Closely correlated | -0.26% |
diseases theme (42 stocks) | 59% Loosely correlated | +1.03% |
therapy theme (24 stocks) | 58% Loosely correlated | +1.03% |
neurological theme (10 stocks) | 57% Loosely correlated | +0.84% |
drugs theme (265 stocks) | 53% Loosely correlated | +5.37% |
More |